CVM GFI #191 Changes to Approved NADAs - New NADAs vs Category II Supplemental NADAs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 27, 2020
August 27, 2020
33b97e61-bc96-497e-9004-842c9543f2f4
Related Documents
CVM GFI #271 Reporting and Mitigating Animal Drug Shortages
Guidance DocumentMay 12, 2023Center for Veterinary Medicine
CVM GFI #261 - Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs
Guidance DocumentJuly 14, 2021Center for Veterinary Medicine
CVM GFI #199 Animal Generic Drug User Fees and Fee Waivers and Reductions
Guidance DocumentDecember 4, 2023Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox